Literature DB >> 15823648

Returning hypertrophy after surgery in a patient with hypertrophic cardiomyopathy caused by a myosin-binding protein C mutation.

Zhyldyz Kabaeva, Andreas Perrot, Bernhard Pilz, Jeanette Schulz-Menger, Friedrich-Wilhelm Mohr, Rainer Dietz, Karl Josef Osterziel.   

Abstract

We report a 13-year follow-up of a patient who underwent both myectomy and septal ablation due to hypertrophic cardiomyopathy caused by a cardiac myosin-binding protein C gene mutation. After myectomy the patient again developed significant septal hypertrophy at the operated septal area with a need for a second interventional therapy. This exceptional case underscores the remarkable ability of the heart muscle to show a continuous hypertrophic process over many years.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823648     DOI: 10.1016/j.ijcard.2005.01.004

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  1 in total

1.  Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene.

Authors:  Philipp Ehlermann; Dieter Weichenhan; Jörg Zehelein; Henning Steen; Regina Pribe; Raphael Zeller; Stephanie Lehrke; Christian Zugck; Boris T Ivandic; Hugo A Katus
Journal:  BMC Med Genet       Date:  2008-10-28       Impact factor: 2.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.